This study explored the complex relationships between HRT use, age at menopause, APOE4 carrier status, lifestyle variables, presence of comorbidities and cognitive outcomes in postmenopausal older-adult women, contributing to the ongoing investigation regarding the efficacy and risks associated with HRT in the context of aging and cognitive decline. The gene discussed is APOE; the disease is Mental deterioration.